Last reviewed · How we verify

NCT06243224

The Effect Of High Intensity Interval Training And Moderate Intensity Continuous Training In Patients With Hypertension

Completed NA Last updated 13 May 2024
What this trial tests

NA trial testing High intensity interval training in Hypertension in 38 participants. Completed in 5 April 2024.

Timeline
15 April 2023
Primary endpoint
15 February 2024
5 April 2024

Quick facts

Lead sponsorAnkara City Hospital Bilkent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment38
Start date15 April 2023
Primary completion15 February 2024
Estimated completion5 April 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 35 to 55, any sex, with Hypertension or Life Style. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of high intensity interval training (HIIT) and moderate intensity continuous training (MICT) in patients with hypertension patient in terms of aerobic capacity, blood pressure level, anxiety and depression scores, quality of life, kinesiophobia levels and sleep quality measurement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High intensity interval training

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06243224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing